Program for Integrated Immunodeficiency and Cellular Therapy (PIICT)
The Program for Integrated Immunodeficiency and Cellular Therapy (PIICT) at Children's Hospital of Philadelphia (CHOP) provides integrated and comprehensive long-term care to children with primary immune deficiencies and functional immune abnormalities following cellular therapies such as hematopoietic stem cell transplant (HSCT) for specific types of leukemia. HSCT may be more commonly known as bone marrow transplant or chimeric antigen receptor T-cell therapy (CART).
Our collaborative program brings together disease experts from Immunology, Cellular Therapy and other specialties to support children and their families as they cope with the long-term effects of their disease, their treatments, and any new health issues that develop.
Conditions We Treat
- Severe Combined Immunodeficiency (SCID) and combined immunodeficiencies
- Chronic Granulomatous Disease (CGD)
- Hemophagocytic Lymphohistiocytosis (HLH)
- Wiskott-Aldrich syndrome (WAS)
- Very Early Onset Inflammatory Bowel Disease (VEO-IBD)
- IPEX syndrome and related immune dysregulation disorders
- Hyper-IGM syndromes Immune abnormalities following cellular therapy
Our Programs and Services
Our Team
Our team includes specialists from Immunology and Cellular Therapy who have expertise in assessing and treating the long-term effects of primary immune deficiencies and related conditions. Your child will be cared for by experienced specialty physicians, dedicated nursing professionals and support staff.